Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis

Andrea L. Murphy; Randa Ataya; Dani Himmelman; Claire O’Reilly; Alan Rosen; Luis Salvador-Carulla; Ruth Martin-Misener; Fred Burge; Stanley Kutcher; David M. Gardner

doi:10.1007/s00127-018-1553-7

Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis

Andrea L. Murphy, Randa Ataya, Dani Himmelman, Claire O’Reilly, Alan Rosen, Luis Salvador-Carulla, Ruth Martin-Misener, Fred Burge, Stanley Kutcher, David M. Gardner

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

31 Citas (Scopus)

Resumen

Purpose: To explore Canadian and Australian community pharmacists’ practice experiences in caring for people at risk of suicide. Methods: We conducted a thematic analysis of 176 responses to an open-ended extension question in an online survey. Results: Four themes were identified and include referrals and triage, accessibility for confiding, emotional toll, and stigma. Subthemes included gatekeeping the medication supply, sole disclosure, planning for end of life, concerns of support people, assessing the validity of suicidality, gaps in the system, not directly asking, ill-equipped, resources in the pharmacy, relying on others to continue care, and attention seeking. Conclusions: Community pharmacists are caring for patients at risk of suicide frequently, and often with patients seeking the help of pharmacists directly. Pharmacists engage in activities and actions that would be considered outside of the traditional dispensing roles and provide support and intervention to people at risk of suicide through collaboration and other mechanisms. Further research to determine appropriate education and training and postvention supports is required.

Idioma original	English
Páginas (desde-hasta)	1173-1184
Número de páginas	12
Publicación	Social Psychiatry and Psychiatric Epidemiology
Volumen	53
N.º	11
DOI	https://doi.org/10.1007/s00127-018-1553-7
Estado	Published - nov. 1 2018

Nota bibliográfica

Funding Information:
This study was funded by the Dalhousie Pharmacy Endowment Fund (DPEF). Funding supported all core activities of the study including survey development, deployment, sample recruitment, and analysis. RA received funding as a research trainee through the DPEF Grant. Funding from the Pharmacy Council of New South Wales supported the Australian component of the study. The initial meetings for ALM and DMG to collaborate with Australian colleagues to prepare the DPEF Grant proposal were supported by funding from the Drug Evaluation Alliance of Nova Scotia through sabbatical support for ALM and DMG. We would like to acknowledge Dr. Timothy F Chen and Ms. Stephanie Webster for the contributions to the successfully funded DPEF Grant and to Ms. Kirstie Smith with her assistance in manuscript formatting. On behalf of all authors, the corresponding author states that there is no conflict of interest.

Funding Information:
Acknowledgements This study was funded by the Dalhousie Pharmacy Endowment Fund (DPEF). Funding supported all core activities of the study including survey development, deployment, sample recruitment, and analysis. RA received funding as a research trainee through the DPEF Grant. Funding from the Pharmacy Council of New South Wales supported the Australian component of the study. The initial meetings for ALM and DMG to collaborate with Australian colleagues to prepare the DPEF Grant proposal were supported by funding from the Drug Evaluation Alliance of Nova Scotia through sabbatical support for ALM and DMG. We would like to acknowledge Dr. Timothy F Chen and Ms. Stephanie Webster for the contributions to the successfully funded DPEF Grant and to Ms. Kirstie Smith with her assistance in manuscript formatting.

Publisher Copyright:
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.

ASJC Scopus Subject Areas

Epidemiology
Social Psychology
Health(social science)
Psychiatry and Mental health

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1007/s00127-018-1553-7

Otros archivos y enlaces

Citar esto

Murphy, A. L., Ataya, R., Himmelman, D., O’Reilly, C., Rosen, A., Salvador-Carulla, L., Martin-Misener, R., Burge, F., Kutcher, S., & Gardner, D. M. (2018). Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis. Social Psychiatry and Psychiatric Epidemiology, 53(11), 1173-1184. https://doi.org/10.1007/s00127-018-1553-7

Murphy, AL, Ataya, R, Himmelman, D, O’Reilly, C, Rosen, A, Salvador-Carulla, L, Martin-Misener, R, Burge, F, Kutcher, S & Gardner, DM 2018, 'Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis', Social Psychiatry and Psychiatric Epidemiology, vol. 53, n.º 11, pp. 1173-1184. https://doi.org/10.1007/s00127-018-1553-7

@article{8d89109c0472438c93a4383bd35225c8,

title = "Community pharmacists{\textquoteright} experiences and people at risk of suicide in Canada and Australia: a thematic analysis",

abstract = "Purpose: To explore Canadian and Australian community pharmacists{\textquoteright} practice experiences in caring for people at risk of suicide. Methods: We conducted a thematic analysis of 176 responses to an open-ended extension question in an online survey. Results: Four themes were identified and include referrals and triage, accessibility for confiding, emotional toll, and stigma. Subthemes included gatekeeping the medication supply, sole disclosure, planning for end of life, concerns of support people, assessing the validity of suicidality, gaps in the system, not directly asking, ill-equipped, resources in the pharmacy, relying on others to continue care, and attention seeking. Conclusions: Community pharmacists are caring for patients at risk of suicide frequently, and often with patients seeking the help of pharmacists directly. Pharmacists engage in activities and actions that would be considered outside of the traditional dispensing roles and provide support and intervention to people at risk of suicide through collaboration and other mechanisms. Further research to determine appropriate education and training and postvention supports is required.",

author = "Murphy, {Andrea L.} and Randa Ataya and Dani Himmelman and Claire O{\textquoteright}Reilly and Alan Rosen and Luis Salvador-Carulla and Ruth Martin-Misener and Fred Burge and Stanley Kutcher and Gardner, {David M.}",

note = "Funding Information: This study was funded by the Dalhousie Pharmacy Endowment Fund (DPEF). Funding supported all core activities of the study including survey development, deployment, sample recruitment, and analysis. RA received funding as a research trainee through the DPEF Grant. Funding from the Pharmacy Council of New South Wales supported the Australian component of the study. The initial meetings for ALM and DMG to collaborate with Australian colleagues to prepare the DPEF Grant proposal were supported by funding from the Drug Evaluation Alliance of Nova Scotia through sabbatical support for ALM and DMG. We would like to acknowledge Dr. Timothy F Chen and Ms. Stephanie Webster for the contributions to the successfully funded DPEF Grant and to Ms. Kirstie Smith with her assistance in manuscript formatting. On behalf of all authors, the corresponding author states that there is no conflict of interest. Funding Information: Acknowledgements This study was funded by the Dalhousie Pharmacy Endowment Fund (DPEF). Funding supported all core activities of the study including survey development, deployment, sample recruitment, and analysis. RA received funding as a research trainee through the DPEF Grant. Funding from the Pharmacy Council of New South Wales supported the Australian component of the study. The initial meetings for ALM and DMG to collaborate with Australian colleagues to prepare the DPEF Grant proposal were supported by funding from the Drug Evaluation Alliance of Nova Scotia through sabbatical support for ALM and DMG. We would like to acknowledge Dr. Timothy F Chen and Ms. Stephanie Webster for the contributions to the successfully funded DPEF Grant and to Ms. Kirstie Smith with her assistance in manuscript formatting. Publisher Copyright: {\textcopyright} 2018, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2018",

month = nov,

day = "1",

doi = "10.1007/s00127-018-1553-7",

language = "English",

volume = "53",

pages = "1173--1184",

journal = "Social Psychiatry and Psychiatric Epidemiology",

issn = "0933-7954",

publisher = "D. Steinkopff-Verlag",

number = "11",

}

TY - JOUR

T1 - Community pharmacists’ experiences and people at risk of suicide in Canada and Australia

T2 - a thematic analysis

AU - Murphy, Andrea L.

AU - Ataya, Randa

AU - Himmelman, Dani

AU - O’Reilly, Claire

AU - Rosen, Alan

AU - Salvador-Carulla, Luis

AU - Martin-Misener, Ruth

AU - Burge, Fred

AU - Kutcher, Stanley

AU - Gardner, David M.

N1 - Funding Information: This study was funded by the Dalhousie Pharmacy Endowment Fund (DPEF). Funding supported all core activities of the study including survey development, deployment, sample recruitment, and analysis. RA received funding as a research trainee through the DPEF Grant. Funding from the Pharmacy Council of New South Wales supported the Australian component of the study. The initial meetings for ALM and DMG to collaborate with Australian colleagues to prepare the DPEF Grant proposal were supported by funding from the Drug Evaluation Alliance of Nova Scotia through sabbatical support for ALM and DMG. We would like to acknowledge Dr. Timothy F Chen and Ms. Stephanie Webster for the contributions to the successfully funded DPEF Grant and to Ms. Kirstie Smith with her assistance in manuscript formatting. On behalf of all authors, the corresponding author states that there is no conflict of interest. Funding Information: Acknowledgements This study was funded by the Dalhousie Pharmacy Endowment Fund (DPEF). Funding supported all core activities of the study including survey development, deployment, sample recruitment, and analysis. RA received funding as a research trainee through the DPEF Grant. Funding from the Pharmacy Council of New South Wales supported the Australian component of the study. The initial meetings for ALM and DMG to collaborate with Australian colleagues to prepare the DPEF Grant proposal were supported by funding from the Drug Evaluation Alliance of Nova Scotia through sabbatical support for ALM and DMG. We would like to acknowledge Dr. Timothy F Chen and Ms. Stephanie Webster for the contributions to the successfully funded DPEF Grant and to Ms. Kirstie Smith with her assistance in manuscript formatting. Publisher Copyright: © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose: To explore Canadian and Australian community pharmacists’ practice experiences in caring for people at risk of suicide. Methods: We conducted a thematic analysis of 176 responses to an open-ended extension question in an online survey. Results: Four themes were identified and include referrals and triage, accessibility for confiding, emotional toll, and stigma. Subthemes included gatekeeping the medication supply, sole disclosure, planning for end of life, concerns of support people, assessing the validity of suicidality, gaps in the system, not directly asking, ill-equipped, resources in the pharmacy, relying on others to continue care, and attention seeking. Conclusions: Community pharmacists are caring for patients at risk of suicide frequently, and often with patients seeking the help of pharmacists directly. Pharmacists engage in activities and actions that would be considered outside of the traditional dispensing roles and provide support and intervention to people at risk of suicide through collaboration and other mechanisms. Further research to determine appropriate education and training and postvention supports is required.

AB - Purpose: To explore Canadian and Australian community pharmacists’ practice experiences in caring for people at risk of suicide. Methods: We conducted a thematic analysis of 176 responses to an open-ended extension question in an online survey. Results: Four themes were identified and include referrals and triage, accessibility for confiding, emotional toll, and stigma. Subthemes included gatekeeping the medication supply, sole disclosure, planning for end of life, concerns of support people, assessing the validity of suicidality, gaps in the system, not directly asking, ill-equipped, resources in the pharmacy, relying on others to continue care, and attention seeking. Conclusions: Community pharmacists are caring for patients at risk of suicide frequently, and often with patients seeking the help of pharmacists directly. Pharmacists engage in activities and actions that would be considered outside of the traditional dispensing roles and provide support and intervention to people at risk of suicide through collaboration and other mechanisms. Further research to determine appropriate education and training and postvention supports is required.

UR - http://www.scopus.com/inward/record.url?scp=85049005696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049005696&partnerID=8YFLogxK

U2 - 10.1007/s00127-018-1553-7

DO - 10.1007/s00127-018-1553-7

M3 - Article

C2 - 29936597

AN - SCOPUS:85049005696

SN - 0933-7954

VL - 53

SP - 1173

EP - 1184

JO - Social Psychiatry and Psychiatric Epidemiology

JF - Social Psychiatry and Psychiatric Epidemiology

IS - 11

ER -

Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto